Endobiliary Ablation Improves Survival for Biliary Tract, Pancreatic Cancers
Endobiliary ablation can extend survival for patients with conditions like cholangiocarcinoma and pancreatic cancers.
UVA Health Researchers Uncover Chemo Drug’s Potential to Treat Heart Failure
A tool created by UVA Health researchers is identifying new treatments for heart failure in drugs approved by the FDA for blood cancer.
Researcher Highlight Q&A: Michael E. Williams, MD, Reducing Chemo Harm for Blood Cancer Patients
Michael E. Williams, MD, is a hematology/oncology researcher at UVA Health, exploring ways to reduce chemotherapy use in blood cancer.
For Breast Cancer, Can Focused Ultrasound Overcome Immunotherapy’s Limitations?
UVA Health launches 2 key clinical trials to see if immunotherapy combined with FUS tumor ablation can prevent breast cancer metastasis.
Expanding the Horizon of Third-Space Endoscopy in Gastroenterology
These procedures offer minimally invasive options for many conditions, including early gastrointestinal cancers.
Advancing Immunotherapy’s Reach With Focused Ultrasound
With a first-of-its-kind focused ultrasound center & trials, UVA Health is positioned to overcome immunotherapy’s cancer-metastases limitation.
The Search for a Less-Toxic Treatment for Aggressive Leukemias
Targeting fusion proteins may provide an improved therapeutic approach for leukemia patients.
Sonodynamic Therapy: Novel, Noninvasive Therapy for Glioblastoma
A groundbreaking clinical trial at UVA Health may shift the approach to treating glioblastoma.
Researcher Highlight Q&A: Todd Bauer, MD, Uncovering Novel Pancreatic & Colon Cancer Targets
Todd Bauer, MD, leads a laboratory searching for what drives chemo-resistance and metastases in his pancreatic and colorectal cancer patients.
Finally, a Unified Approach to Managing AML
With acute myeloid leukemia classification overseen by 3 separate guidelines, Firas El Chaer, MD, is working to bring order to the chaos.